References
1. Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics.Nat. Rev. Drug Discov. 2010;9(10):767–774.
2. Jacobse J, Ten Voorde W, Rissmann R, Burggraaf J, Ten Cate R, Schrier L. The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases. Eur. J. Pediatr.2019;178(1):17–20.
3. Donnelly RF, Raghu Raj Singh T, Larraneta. E, McCrudden MTC.Microneedles for Drug and Vaccine Delivery and Patient Monitoring . Chichester, UK: John Wiley & Sons, Ltd; 2018.
4. Gupta J, Felner EI, Prausnitz MR. Rapid Pharmacokinetics of Intradermal Insulin Administered Using Microneedles in Type 1 Diabetes Subjects. Diabetes Technol. Ther. 2011;13(4):451–456.
5. McVey E, Hirsch L, Sutter DE, Kapitza C, Dellweg S, Clair J, Rebrin K … Pettis RJ. Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion. J Diabetes Sci Technol. 2012;6(4):743–754.
6. Kochba E, Levin Y, Raz I, Cahn A. Improved Insulin Pharmacokinetics Using a Novel Microneedle Device for Intradermal Delivery in Patients with Type 2 Diabetes.Diabetes Technol. Ther. 2016;18(9):525–531.
7. Milewski M, Manser K, Nissley BP, Mitra A. Analysis of the absorption kinetics of macromolecules following intradermal and subcutaneous administration. Eur. J. Pharm. Biopharm. 2015;89:134–144.
8. Hróbjartsson A, Emanuelsson F, Thomsen ASS, Hilden J, Brorson S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. Int. J. Epidemiol. 2014;43(4):1272–1283.
9. Levin Y, Kochba E, Kenney R. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: Are all delivery methods the same? Vaccine2014;32(34):4249–4252.
10. Mahler SM, Marquis CP, Brown G, Roberts A, Hoogenboom HR. Cloning and expression of human V- genes derived from phage display libraries as fully assembled human anti-TNFα monoclonal antibodies.Immunotechnology 1997;3(1):31–43.
11. Hermeling S, Crommelin DJA, Schellekens H, Jiskoot W. Structure-immunogenicity relationships of therapeutic proteins.Pharm. Res. 2004;21(6):897–903.
12. Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L … Wolbink GJ. Clinical response to adalimumab: Relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann. Rheum. Dis. 2007;66(7):921–926.
13. Bartelds GM, Krieckaert CLM, Nurmohamed MT, Van Schouwenburg PA, Lems WF, Twisk JWR … Wolbink JG. Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up. JAMA2011;305(14):1460.
14. Dillingh MR, Reijers JAA, Malone KE, Burggraaf J, Bahrt K, Yamashita L … Moerland M. Clinical evaluation of humira® biosimilar ons-3010 in healthy volunteers: Focus on pharmacokinetics and pharmacodynamics. Front. Immunol. 2016;7:508.
15. Hicks CL, Von Baeyer CL, Spafford PA, Van Korlaar I, Goodenough B. The Faces Pain Scale - Revised: Toward a common metric in pediatric pain measurement. Pain. 2001;93(2):173–83.
16. Pouw MF, Krieckaert CL, Nurmohamed MT, Van Der Kleij D, Aarden L, Rispens T, et al. Key findings towards optimising adalimumab treatment: The concentration-effect curve. Ann Rheum Dis. 2015;74(3):513–8.
17. Briers D, Duncan DD, Hirst E, Kirkpatrick SJ, Larsson M, Steenbergen W, Stromberg T, Thompson OB. Laser speckle contrast imaging: theoretical and practical limitations. J. Biomed. Opt. 2013;18(6):066018.
18. Everett JS, Budescu M, Sommers MS. Making Sense of Skin Color in Clinical Care. Clin Nurs Res. 2012;21(4):495–516.
19. Del Bino S, Bernerd F. Variations in skin colour and the biological consequences of ultraviolet radiation exposure. Br J Dermatol. 2013;169(SUPPL. 3):33–40.
20. Vlieland ND, Nejadnik MR, Gardarsdottir H, Romeijn S, Sediq AS, Bouvy ML … Jiskoot W. The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors. Pharm. Res. 2018;35(42).
21. Kueltzo LA, Middaugh CR. Ultravioloet absorption spectroscopy. In: Jiskoot W, Crommelin DJA, editors. Methods for structural analysis of protein pharmaceuticals. Arlington: AAPS Press; 2005.
22. R Core Team (2017). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/.
23. Berends SE, Strik AS, Van Selm JC, Löwenberg M, Ponsioen CY, D’Haens GR, et al. Explaining Interpatient Variability in Adalimumab Pharmacokinetics in Patients with Crohn’s Disease. Ther Drug Monit. 2018;40(2):202–11.
24. Lindbom L, Ribbing J, Jonsson EN. Perl-speaks-NONMEM (PsN) - A Perl module for NONMEM related programming. Comput Methods Programs Biomed. 2004;75(2):85–94.
25. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–68.
26. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24(7):585–94.
27. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv. Drug Deliv. Rev.2012;64(14):1547–1568.
28. Gupta J, Park SS, Bondy B, Felner EI, Prausnitz MR. Infusion pressure and pain during microneedle injection into skin of human subjects. Biomaterials. 2011;32(28)6823-31.
29. Usach I, Martinez R, Festini T, Peris JE. Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. Adv Ther. 2019;36(11):2986–96.
30. Mathaes R, Koulov A, Joerg S, Mahler HC. Subcutaneous Injection Volume of Biopharmaceuticals—Pushing the Boundaries. J. Pharm. Sci. 2016;105(8):2255–2259.
31. Heise T, Nosek L, Dellweg S, Zijlstra E, Praestmark KA, Kildegaard J … Sparre T. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single- centre, randomized controlled trial. Diabetes, Obes. Metab.2014;16(10):971–976.
32. Jørgensen JT, Rømsing J, Rasmussen M, Møller-Sonnergaard J, Vang L, Musæus L. Pain assessment of subcutaneous injections. Ann Pharmacother. 1996;30(7–8):729–32.
33. Richter WF, Bhansali SG, Morris ME. Mechanistic determinants of biotherapeutics absorption following SC administration. AAPS J. 2012;14(3):559–70.
34. Supersaxo A, Hein WR, Steffen H. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm. Res.1990;7(2):167–9.
35. O’Morchoe CCC, Jones WR, Jarosz HM. Temperature dependence of protein transport across lymphatic endothelium in vitro. J Cell Biol. 1984;98(2):629–40.
36. Astrup A, Bülow J, Madsen J. Skin temperature and subcutaneous adipose blood flow in man. Scand J Clin Lab Invest. 1980;40(2):135–8.
37. Olszewski W, Engeset A, Icger PM, Sokolowski J, Theodorsen L. Flow and Composition of Leg Lymph in Normal Men during Venous Stasis, Muscular Activity and Local Hyperthermia. Acta Physiol Scand. 1977;99(2):149–55.
38. Ryan TJ, Mortimer PS, Jones RL. Lymphatics of the Skin: Neglected but Important. Int J Dermatol. 1986;25(7):411–9.
39. Blatter C, Meijer EFJ, Nam AS, Jones D, Bouma BE, Padera TP, Vakoc BJ. In vivo label-free measurement of lymph flow velocity and volumetric flow rates using Doppler optical coherence tomography. Sci. Rep.2016;6:29035.
40. Dul M, Stefanidou M, Porta P, Serve J, O’Mahony C, Malissen B, et al. Hydrodynamic gene delivery in human skin using a hollow microneedle device. J Control Release. 2017;265:120–31.
41. Rini CJ, McVey E, Sutter D, Keith S, Kurth HJ, Nosek L, et al. Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear. Drug Deliv Transl Res. 2015;5(4):332–45.
42. Kabashima K, Honda T, Ginhoux F, Egawa G. The immunological anatomy of the skin. Nat. Rev. Immunol.2019;19(1):19–30.
43. Lambert PH, Laurent PE. Intradermal vaccine delivery: Will new delivery systems transform vaccine administration? Vaccine. 2008;26(26):3197–208.
44. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-Based Vaccines. Curr Top Microbiol Immunol. 2009;333:369-93.
45. Büttel IC, Chamberlain P, Chowers Y, Ehmann F, Greinacher A, Jefferis R … Schneider CK. Taking immunogenicity assessment of therapeutic proteins to the next level. Biologicals2011;39(2):100–109.
46. Rittié L, Fisher GJ. Natural and sun-induced aging of human skin.Cold Spring Harb. Perspect. Med. 2015;5(1):1–14.